Frazier Life Sciences Management, L.P.

Holdings History for Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA)

Symbol: NTLA on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2024		-0.24%	$0	0	-203,684	-100%	$12.49	Q2 2024
31 Mar 2024	0.24%	0%	$5,603,347	203,684	0		$27.51	Q1 2024
31 Dec 2023	0.33%	0%	$6,210,325	203,684	0		$30.49	Q4 2023
30 Sep 2023	0.43%	0%	$6,440,488	203,684	0		$31.62	Q3 2023
30 Jun 2023	0.5%	0%	$8,306,234	203,684	0		$40.78	Q2 2023
31 Mar 2023	0.55%	0%	$7,591,303	203,684	0		$37.27	Q1 2023
31 Dec 2022	0.44%	0%	$7,106,535	203,684	0		$34.89	Q4 2022
30 Sep 2022	0.9%	0%	$11,398,000	203,684	0		$55.96	Q3 2022
30 Jun 2022	1%	0%	$10,543,000	203,684	0		$51.76	Q2 2022
31 Mar 2022	1.3%	0%	$14,802,000	203,684	0		$72.67	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.